Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $44,286 | $46,444 | $40,304 | $39,175 |
| % Growth | -4.6% | 15.2% | 2.9% | – |
| Cost of Goods Sold | $13,205 | $14,236 | $13,695 | $12,255 |
| Gross Profit | $31,081 | $32,208 | $31,694 | $26,920 |
| % Margin | 70.2% | 69.3% | 78.6% | 68.7% |
| R&D Expenses | $7,394 | $6,728 | $6,501 | $5,692 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9,183 | $10,765 | $8,785 | $9,555 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,252 | $6,840 | $0 | $3,547 |
| Operating Expenses | $23,829 | $24,333 | $15,286 | $18,794 |
| Operating Income | $14,450 | $12,980 | $13,149 | $8,126 |
| % Margin | 32.6% | 27.9% | 32.6% | 20.7% |
| Other Income/Exp. Net | $0 | -$6,865 | -$3,157 | -$289 |
| Pre-Tax Income | $6,758 | $6,115 | $9,992 | $7,837 |
| Tax Expense | $1,204 | $1,017 | $1,909 | $1,558 |
| Net Income | $5,560 | $5,400 | $8,371 | $6,223 |
| % Margin | 12.6% | 11.6% | 20.8% | 15.9% |
| EPS | 4.45 | 4.3 | 6.69 | 4.97 |
| % Growth | 3.5% | -35.7% | 34.6% | – |
| EPS Diluted | 4.43 | 4.3 | 6.66 | 4.95 |
| Weighted Avg Shares Out | 1,249 | 1,256 | 1,252 | 1,253 |
| Weighted Avg Shares Out Dil | 1,256 | 1,256 | 1,257 | 1,258 |
| Supplemental Information | – | – | – | – |
| Interest Income | $413 | $19 | $239 | $3 |
| Interest Expense | $749 | $710 | $465 | $368 |
| Depreciation & Amortization | $3,586 | $2,955 | $3,108 | $2,686 |
| EBITDA | $11,033 | $11,076 | $13,510 | $11,251 |
| % Margin | 24.9% | 23.8% | 33.5% | 28.7% |